Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.44 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.44 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526142 | 0.98 | ECE1 (0.54) | ECE1TSHRLMNATHRBBLM | |
| SCHEMBL13788601 | 0.98 | ECE1 (0.54) | ECE1TSHRLMNATHRBBLM | |
| SCHEMBL18571198 | 0.86 | LMNA (0.58) | ECE1TSHRLMNATHRBBLM | |
| SCHEMBL1769661 | 0.86 | ATM (0.55) | TSHRLMNATHRBBLMKMT2A | |
| SCHEMBL9717431 | 0.85 | ECE1 (0.65) | ECE1LMNAITGB3ITGA2BFAAH | |
| SCHEMBL13788598 | 0.85 | PRMT1 (0.57) | TSHRLMNATHRBBLMKMT2A | |
| SCHEMBL385127 | 0.83 | ECE1 (0.58) | ECE1TSHRLMNATHRBBLM | |
| SCHEMBL20663420 | 0.83 | PRMT1 (0.61) | TSHRLMNATHRBBLMKMT2A | |
| SCHEMBL26869544 | 0.83 | PRMT1 (0.61) | TSHRLMNATHRBBLMKMT2A | |
| SCHEMBL18250764 | 0.83 | LMNA (0.61) | ECE1TSHRLMNATHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115057790-B | Method for recovering 3-aminopropionic acid from 3-aminopropionic acid waste liquid | 杭州鑫富科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115057790-A | Method for recovering 3-aminopropionic acid from 3-aminopropionic acid waste liquid | 杭州鑫富科技有限公司 | 2022-09-16 | — | — | CN | claimed |
| EP-1313703-B1 | PRODRUGS TO NMDA RECEPTOR LIGANDS | HOFFMANN LA ROCHE (CH) | 2008-02-13 | — | — | EP | claimed |
| CN-1227230-C | Prodrugs to NMDA receptor ligands | HOFFMANN LA ROCHE (CH) | 2005-11-16 | — | — | CN | claimed |
| CN-1447793-A | Prodrugs to NMDA receptor ligands | HOFFMANN LA ROCHE (CH) | 2003-10-08 | — | — | CN | claimed |
| US-6407235-B1 | A NMDA (N-METHYL-D-ASPARTATE)-RECEPTOR-SUBTYPE SELECTIVE BLOCKERS; PRODRUGS HAVE IMPROVED SOLUBILITY AND ARE HYDROLYZED IN VIVO; FOR EXAMPLE, THE 4-AMINOMETHYL-BENZOIC ACID ESTER OF THE PHENOL, OR THE PHOSPHATE ESTER | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | claimed |
| US-20020040037-A1 | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol | EVOTEC INTERNATIONAL GMBH (DE) | 2002-04-04 | — | — | US | claimed |
| EP-3650464-B1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | SHANGPHARMA INNOVATION INC (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2025222300-A1 | ATRIAL NATRIURETIC PEPTIDE CONSTRUCTS FOR TARGETED PAYLOAD DELIVERY TO NPR-C EXPRESSING CELLS | PROTEINQURE INC. (CA) | 2025-10-30 | — | — | WO | disclosed |
| CN-120136965-A | Isolated polypeptide of targeted MPP8 protein and application thereof | 苏州系统医学研究所 | 2025-06-13 | — | — | CN | disclosed |
| EP-4554959-A2 | COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE | Pep2Tango Therapeutics Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| CN-115057790-B | Method for recovering 3-aminopropionic acid from 3-aminopropionic acid waste liquid | 杭州鑫富科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-115057790-B | Method for recovering 3-aminopropionic acid from 3-aminopropionic acid waste liquid | 杭州鑫富科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2002016321-A1 | PRODRUGS TO NMDA RECEPTOR LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-02-28 | — | — | WO | disclosed |
| US-5965106-A | ADMINISTERING TARGETING MOIETY COUPLED TO AFFINITY COMPONENT, WHEREIN TARGETING MOIETY HAS AFFINITY FOR BINDING SITES IN TARGET AREA, AND BINDING PARTNER TO AFFINITY COMPONENT COUPLED TO FUNCTIONAL MOIETY TO LOCALIZE FUNCTIONAL MOIETY IN TARGET | PERIMMUNE HOLDINGS, INC. (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0220245-B1 | METHOD FOR DETERMINING MIMOTOPES | COSELCO MIMOTOPES PTY. LTD. (AU) | 1992-07-08 | — | — | EP | disclosed |
| US-4833092-A | Method for determining mimotopes | COMMONWEALTH SERUM LABORATORIES COMMISSION (AU) | 1989-05-23 | — | — | US | disclosed |
| EP-0220245-A4 | METHOD FOR DETERMINING MIMOTOPES. | COMMW SERUM LAB COMMISSION (AU) | 1988-01-26 | — | — | EP | disclosed |
| EP-0220245-A1 | METHOD FOR DETERMINING MIMOTOPES. | COMMW SERUM LAB COMMISSION (AU) | 1987-05-06 | — | — | EP | disclosed |
| WO-1986006487-A1 | METHOD FOR DETERMINING MIMOTOPES | COMMONWEALTH SERUM LABORATORIES COMMISSION (AU) | 1986-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040037-A1 | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol | HAO2, CYP2B6, CBR1 | ECE1 822/4885TSHR 2233/4885LMNA 4084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.